MGNX

Macrogenics Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 2/10
  • Value↓ 3/10
Macrogenics sales and earnings growth
MGNX Growth
Fair
  • Revenue Y/Y↓ -0.31%
  • EPS Y/Y↓ -10.28%
  • FCF Y/Y↓ -15.33%
Macrogenics gross and profit margin trends
MGNX Profitability
Low
  • Gross margin ↑ 75.90%
  • EPS margin↓ -49.90%
  • ROIC 5Y↓ -40.20%
Macrogenics net debt vs free cash flow
MGNX Risk
Good
  • Debt / Equity↓ 1.9
  • Debt / FCF↓ 0.6
  • Interest coverage↓ -7.8

Macrogenics stock volatility is higher than the overall market. We give it a Good risk rating.

More Biotechnology stocks ↗